Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:AED - BE0003851681 - REIT

65.35 EUR
-0.35 (-0.53%)
Last: 11/25/2025, 7:00:00 PM
Fundamental Rating

4

AED gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. AED has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, AED is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AED had positive earnings in the past year.
AED had a positive operating cash flow in the past year.
Each year in the past 5 years AED has been profitable.
Each year in the past 5 years AED had a positive operating cash flow.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.73%, AED is in line with its industry, outperforming 54.76% of the companies in the same industry.
The Return On Equity of AED (4.96%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.52%, AED perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AED is in line with the industry average of 3.52%.
The 3 year average ROIC (3.33%) for AED is below the current ROIC(3.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AED has a Profit Margin of 49.82%. This is in the better half of the industry: AED outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of AED has declined.
The Operating Margin of AED (77.70%) is better than 73.81% of its industry peers.
In the last couple of years the Operating Margin of AED has remained more or less at the same level.
AED has a better Gross Margin (97.93%) than 97.62% of its industry peers.
In the last couple of years the Gross Margin of AED has remained more or less at the same level.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

AED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AED remains at a similar level compared to 1 year ago.
AED has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that AED is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AED (0.81) is comparable to the rest of the industry.
The Debt to FCF ratio of AED is 24.91, which is on the high side as it means it would take AED, 24.91 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 24.91, AED is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
AED's Debt to Equity ratio of 0.58 is fine compared to the rest of the industry. AED outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.81
ROIC/WACC0.58
WACC6.02%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
AED has a Current ratio (0.35) which is in line with its industry peers.
A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
With a Quick ratio value of 0.35, AED perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.94%, which is quite impressive.
Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
The Revenue has grown by 8.06% in the past year. This is quite good.
The Revenue has been growing by 23.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.12% yearly.
The Revenue is expected to grow by 5.03% on average over the next years.
EPS Next Y3.46%
EPS Next 2Y3.11%
EPS Next 3Y3.12%
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.33%
Revenue Next 3Y5.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.64 indicates a correct valuation of AED.
AED's Price/Earnings ratio is in line with the industry average.
AED's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.98.
A Price/Forward Earnings ratio of 12.48 indicates a correct valuation of AED.
AED's Price/Forward Earnings is on the same level as the industry average.
AED is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.64
Fwd PE 12.48
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AED is valued a bit more expensive than 61.90% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AED indicates a slightly more expensive valuation: AED is more expensive than 76.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 29.98
EV/EBITDA 20.35
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)3.95
PEG (5Y)N/A
EPS Next 2Y3.11%
EPS Next 3Y3.12%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.15%, AED is a good candidate for dividend investing.
AED's Dividend Yield is slightly below the industry average, which is at 5.87.
Compared to an average S&P500 Dividend Yield of 2.41, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.11%
EPS Next 3Y3.12%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (11/25/2025, 7:00:00 PM)

65.35

-0.35 (-0.53%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28 2025-10-28
Earnings (Next)02-17 2026-02-17/amc
Inst Owners40.14%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.11B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts76.67
Price Target75.52 (15.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)1.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 13.64
Fwd PE 12.48
P/S 8.81
P/FCF 29.98
P/OCF 10.64
P/B 0.88
P/tB 0.9
EV/EBITDA 20.35
EPS(TTM)4.79
EY7.33%
EPS(NY)5.23
Fwd EY8.01%
FCF(TTM)2.18
FCFY3.34%
OCF(TTM)6.14
OCFY9.4%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.95
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.81
F-Score7
WACC6.02%
ROIC/WACC0.58
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y3.46%
EPS Next 2Y3.11%
EPS Next 3Y3.12%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.38%
Revenue Next 2Y5.33%
Revenue Next 3Y5.03%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.44%
EBIT Next 3Y6.53%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


Can you provide the valuation status for AEDIFICA?

ChartMill assigns a valuation rating of 3 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


What are the PE and PB ratios of AEDIFICA (AED.BR) stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 13.64 and the Price/Book (PB) ratio is 0.88.


How sustainable is the dividend of AEDIFICA (AED.BR) stock?

The dividend rating of AEDIFICA (AED.BR) is 4 / 10 and the dividend payout ratio is 105.58%.